Table 1

Baseline characteristics of the Heinz Nixdorf Recall study cohort also stratified by lack of social support and social integration

Total cohort
(n=4139)
Lack of instrumental supportLack of emotional supportLack of financial supportLack of social integrationMissings
No
(n=3638)
Yes
(n=501)
No
(n=3480)
Yes
(n=659)
No
(n=3232)
Yes
(n=907)
No
(n=3830)
Yes
(n=309)
N (%)
Age (years), mean (SD)59.1 (7.7)59.0 (7.7)59.7 (8.0)59.0 (7.7)59.5 (7.7)58.9 (7.7)59.8 (7.7)59.0 (7.6)60.4 (8.4)0 (0)
Male sex, N (%)1934 (46.7)1739 (47.8)195 (38.9)*1645 (47.3)289 (43.9)1468 (45.4)466 (51.4)1857 (48.5)77 (24.9)*0 (0)
Education (years), N (%)****1 (0.1)
 ≤10,458 (11.1)377 (10.4)81 (16.2)353 (10.1)105 (15.9)324 (10.0)134 (14.8)377 (9.8)81 (26.2)
 11–132302 (55.6)2019 (55.5)283 (56.5)1941 (55.8)361 (54.8)1848 (57.2)454 (50.1)2137 (55.8)165 (53.4)
 14–17917 (22.2)821 (22.6)96 (19.2)778 (22.4)139 (21.2)684 (21.2)233 (25.7)874 (22.8)43 (13.9)
 ≥18461 (11.1)420 (11.5)41 (8.1)407 (11.7)54 (8.1)376 (11.6)85 (9.4)441 (11.6)20 (6.5)
Monthly household equivalent income (€), mean (SD)1590 (710)1613 (714)1419 (650)*1620 (719)1429 (637)*1612 (710)1510 (702)*1614 (708)1300 (665)*252 (6.1)
No employment, N (%)2234 (54.0)1924 (52.9)310 (61.9)*1843 (53.0)391 (59.3)*1703 (52.7)531 (58.5)*2034 (53.1)200 (64.7)*0 (0)
Depression (score), median (IQR)7.0 (4.0–11.0)6.0 (3.0–10.0)10.0 (6.0–16.1)*6.0 (3.0–10.0)10.4 (6.0–16.0)*6.0 (3.0–10.0)8.0 (5.0–13.0)*6.0 (4.0–10.0)9.0 (5.7–15.0)*101 (2.4)
Current smoking, N (%)955 (23.1)825 (22.7)130 (25.9)797 (22.9)158 (24.0)723 (22.4)232 (25.6)846 (22.1)109 (35.3)*0 (0)
Alcohol consumption (g/week), median (IQR)13.9 (0.0–66.0)13.9 (0.0–69.2)6.9 (0.0–55.3)*13.9 (0.0–67.2)8.2 (0.0–55.6)13.9 (0.0–63.9)13.9 (0.0–69.5)13.9 (0.0–69.3)0.0 (0.0–27.8)*72 (1.7)
No regular physical activity, N (%)1960 (47.4)1682 (46.2)278 (55.5)*1617 (46.5)343 (52.0)1455 (45.0)505 (55.7)*1742 (45.5)218 (70.6)*0 (0)
BMI (kg/m2), mean (SD)27.8 (4.6)27.8 (4.6)27.7 (4.5)27.8 (4.6)28.2 (4.9)27.7 (4.6)28.1 (4.9)27.8 (4.6)27.8 (5.2)16 (0.4)
SBP (mm Hg), mean (SD)132.4 (20.6)132.6 (20.4)130.6 (21.2)132.4 (20.3)132.3 (21.8)132.1 (20.3)133.5 (21.5)132.4 (20.4)131.6 (23.0)1 (0.1)
LDL (mg/dL), mean (SD)147.1 (36.1)147.1 (35.9)146.8 (37.2)147.4 (36.2)145.2 (35.2)147.3 (36.0)146.1 (36.3)147.0 (36.1)147.9 (35.9)32 (0.8)
HDL (mg/dL), median (IQR)56.0 (46.0–69.0)56.0 (47.0–69.0)57.0 (46.0–70.0)56.0 (46.0–69.0)57.0 (46.8–69.0)57.0 (47.0–69.0)55.0 (45.0–69.0)56.0 (46.0–69.0)57.0 (48.0–69.0)20 (0.5)
HbA1c (%), mean (SD)5.49 (0.79)5.49 (0.79)5.51 (0.82)5.50 (0.77)5.50 (0.90)5.48 (0.75)5.53 (0.92)5.49 (0.79)5.55 (0.77)47 (1.1)
Antihypertensives, N (%)1280 (30.9)1100 (30.2)180 (35.9)1070 (30.7)210 (31.9)988 (30.6)292 (32.2)1172 (30.6)108 (35.0)0 (0)
Lipid-lowering drugs, N (%)353 (9.0)312 (9.1)41 (8.5)302 (9.2)51 (8.2)280 (9.2)73 (8.5)329 (9.1)24 (8.0)225 (5.4)
Antidiabetics, N (%)184 (4.7)163 (4.7)21 (4.2)156 (4.7)28 (4.5)136 (4.4)48 (5.6)162 (4.5)22 (7.4)225 (5.4)
Antidepressants, N (%)200 (5.1)153 (4.5)47 (9.8)*146 (4.4)54 (8.6)*145 (4.7)55 (6.4)178 (4.9)22 (7.4)226 (5.5)
Anxiolytics, N (%)91 (2.3)75 (2.2)16 (3.3)71 (2.2)20 (3.2)59 (1.9)32 (3.7)77 (2.1)14 (4.7)225 (5.4)
  • *P<0.001 versus no lack.

  • BMI, body mass index; HbA1c, glycated haemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SBP, systolic blood pressure.